The call for participation is open for the second UMZH Precision Digital Therapeutics Summer School, a five-day program scheduled for 17 to 21 August 2026 in Zurich. The announcement promises a working format rather than a lecture series: participants will collaborate with clinicians and patients over the course of the week.

The program title, decoded

For anyone following digital health, the program title carries real weight. Digital therapeutics, commonly shortened to DTx in the industry, refers to software-based medical interventions designed to prevent, manage, or treat health conditions. The category sits apart from the broader wellness-app market because DTx products are built around clinical evidence and are typically subject to regulatory oversight. Regulators in several countries have begun creating review pathways for software-based treatments, and health systems have started reimbursing a small but growing number of these products.

Digital therapeutics already covers a broad range of conditions, from mental health to chronic disease management, and the software takes several forms: apps that deliver structured therapy, programs that coach patients through daily treatment decisions, and tools that adjust a care plan based on reported symptoms.

The "precision" in the title points to precision medicine, the approach that tailors treatment to an individual patient's data and circumstances instead of applying a one-size-fits-all protocol. Digital therapeutics fits naturally into that framework: software can be adapted to a patient's biology, behavior, and reported symptoms in ways that a pill cannot. Put the two together and the summer school's focus comes into view. The program is about building software treatments that adapt to individual patients, and doing that work in close contact with the people who deliver and receive care.

The clinical angle

That emphasis on clinicians and patients is the most concrete detail in the announcement, and it is worth treating as a design choice. Summer schools in technical fields often default to slide decks and guest lectures. This program appears to be organized around direct collaboration, which means the organizers are treating clinical input and patient experience as working material, not background context.

A recurring criticism of digital health products is that they are built by engineers in isolation and then handed to clinical settings where they do not quite fit. The familiar failure modes include a symptom tracker that adds documentation burden for nurses, a patient app that ignores how older adults use phones day to day, and a dashboard that gives clinicians more data than they can act on. A program that puts clinicians and patients in the room with participants for an entire week is an attempt to close that gap before the building starts. Working with patients in a teaching context usually means more than interviewing them; it means observing how they experience treatment, what they struggle to communicate, and where the gaps in their care sit. Those are the details that never make it into a requirements document.

The location reinforces the theme. Zurich anchors one of Europe's larger life-sciences and medical research communities, which means the program draws on a deep pool of local clinical expertise and an established biomedical industry. For a school centered on precision care, that environment matters.

The value of a working week

For the right participant, the value of a five-day intensive like this is sustained contact. Conferences give you twenty-minute conversations in corridors. A summer school gives you days of shared work with the same group of people. In a field as young as digital therapeutics, where the core questions are still being defined, sustained collaboration tends to matter more than any single talk or workshop.

For early-career researchers and clinicians in particular, a program like this offers something difficult to find in a standard academic setting: a chance to work across disciplines with people who see the same problem from different angles. A computer scientist learns how a clinical team thinks about risk, and a clinician learns what is feasible to build in practice.

The program is described as the second edition, which means a first edition has already run and established the format. The organizers chose to bring it back for a new cohort in 2026, and that return suggests the first edition produced something the organizers considered worth repeating.

The announcement does not fully specify who belongs in the room. Researchers, clinicians, and software developers working on health technology are the most obvious audience, though eligibility details have not been published. The announcement does say that participation is being actively sought: this is a call for participation, not a notice that seats have already been filled. The hashtags attached to the announcement, #dtx and #education, frame the event as both a field-specific gathering and a teaching program, which fits the dual character of the week: learning the craft of digital therapeutics while contributing to its development.

Practical questions remain

Several practical details are still missing. There is no application deadline, no tuition figure, and no published curriculum beyond the clinician and patient collaboration at the heart of the program. Those details will presumably follow in a later announcement. For now, the confirmed facts are the dates, the host city, the edition number, and the collaborative structure of the week.

For prospective participants, the practical takeaway is straightforward. If your work touches digital therapeutics, precision medicine, clinical research, or patient-facing health technology, a five-day program in Zurich with clinicians and patients as collaborators deserves your attention. The call is open, the dates are fixed, and the organizers are looking for people to join the second cohort.